How fragile the positive results of Chinese herbal medicine randomized controlled trials on irritable bowel syndrome are?
Abstract Objective The fragility index (FI), which is the minimum number of changes in status from "event" to "non-event" resulting in a loss of statistical significance, serves as a significant supplementary indicator for clinical physicians in interpreting clinical trial result...
Saved in:
Main Authors: | Minjing Luo (Author), Jinghan Huang (Author), Yingqiao Wang (Author), Yilin Li (Author), Zhihan Liu (Author), Meijun Liu (Author), Yunci Tao (Author), Rui Cao (Author), Qianyun Chai (Author), Jianping Liu (Author), Yutong Fei (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Overview of Systematic Reviews of Herbal Medicine for Irritable Bowel Syndrome
by: Hyejin Jun, et al.
Published: (2022) -
Medicinal Herbal Recommendation for Irritable Bowel Syndrome in Medieval Persian Medicine
by: Farshad AMINI-BEHBAHANI, et al.
Published: (2019) -
Systematic review and meta-analysis of Chinese herbal formula Tongxie Yaofang for diarrhea-predominant irritable bowel syndrome: Evidence for clinical practice and future trials
by: Shi-Bing Liang, et al.
Published: (2022) -
Metabolomics analysis of herb-partitioned moxibustion treatment on rats with diarrhea-predominant irritable bowel syndrome
by: Xianwei Lin, et al.
Published: (2019) -
Evaluation of two laboratory model methods for diarrheal irritable bowel syndrome
by: Qian Chen, et al.
Published: (2023)